163 related articles for article (PubMed ID: 27399689)
1. Compound K Attenuates the Development of Atherosclerosis in ApoE(-/-) Mice via LXRα Activation.
Zhou L; Zheng Y; Li Z; Bao L; Dou Y; Tang Y; Zhang J; Zhou J; Liu Y; Jia Y; Li X
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399689
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid induces macrophage cholesterol efflux and inhibits atherosclerotic plaque formation in apoE-deficient mice.
Zhou W; Lin J; Chen H; Wang J; Liu Y; Xia M
Br J Nutr; 2015 Aug; 114(4):509-18. PubMed ID: 26201974
[TBL] [Abstract][Full Text] [Related]
3. UFM1 Protects Macrophages from oxLDL-Induced Foam Cell Formation Through a Liver X Receptor α Dependent Pathway.
Pang Q; Xiong J; Hu XL; He JP; Liu HF; Zhang GY; Li YY; Chen FL
J Atheroscler Thromb; 2015; 22(11):1124-40. PubMed ID: 26040753
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
5. Macrophage Lxrα reduces atherosclerosis in Ldlr
Yin Y; Zeng S; Li Y; Wu Z; Huang D; Gao P
Biochem Biophys Res Commun; 2020 Aug; 529(3):540-547. PubMed ID: 32736671
[TBL] [Abstract][Full Text] [Related]
6. G004, a synthetic sulfonylurea compound, exerts anti-atherosclerosis effects by targeting SIRT1 in ApoE
Qian L; Ma L; Wu G; Yu Q; Lin H; Ying Q; Wen D; Gao C
Vascul Pharmacol; 2017 Feb; 89():49-57. PubMed ID: 28069546
[TBL] [Abstract][Full Text] [Related]
7. Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis.
Freigang S; Ampenberger F; Spohn G; Heer S; Shamshiev AT; Kisielow J; Hersberger M; Yamamoto M; Bachmann MF; Kopf M
Eur J Immunol; 2011 Jul; 41(7):2040-51. PubMed ID: 21484785
[TBL] [Abstract][Full Text] [Related]
8. Tiaogan daozhuo formula attenuates atherosclerosis via activating AMPK -PPARγ-LXRα pathway.
Zhang Y; Zeng M; Zhang X; Yu Q; Wang L; Zeng W; Wang Y; Suo Y; Jiang X
J Ethnopharmacol; 2024 Apr; 324():117814. PubMed ID: 38286155
[TBL] [Abstract][Full Text] [Related]
9. Activation of soluble guanylyl cyclase prevents foam cell formation and atherosclerosis.
Tsou CY; Chen CY; Zhao JF; Su KH; Lee HT; Lin SJ; Shyue SK; Hsiao SH; Lee TS
Acta Physiol (Oxf); 2014 Apr; 210(4):799-810. PubMed ID: 24299003
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
[TBL] [Abstract][Full Text] [Related]
11. Stimulatory effects of cardiotrophin 1 on atherosclerosis.
Konii H; Sato K; Kikuchi S; Okiyama H; Watanabe R; Hasegawa A; Yamamoto K; Itoh F; Hirano T; Watanabe T
Hypertension; 2013 Nov; 62(5):942-50. PubMed ID: 24041953
[TBL] [Abstract][Full Text] [Related]
12. 2,3,4',5-tetrahydroxystilbene-2-O-β-d-glycoside attenuates atherosclerosis in apolipoprotein E-deficient mice: role of reverse cholesterol transport.
Chen X; Tang K; Peng Y; Xu X
Can J Physiol Pharmacol; 2018 Jan; 96(1):8-17. PubMed ID: 28863273
[TBL] [Abstract][Full Text] [Related]
13. Alteration of volume-regulated chloride channel during macrophage-derived foam cell formation in atherosclerosis.
Hong L; Xie ZZ; Du YH; Tang YB; Tao J; Lv XF; Zhou JG; Guan YY
Atherosclerosis; 2011 May; 216(1):59-66. PubMed ID: 21338988
[TBL] [Abstract][Full Text] [Related]
14. Effects of FXR in foam-cell formation and atherosclerosis development.
Guo GL; Santamarina-Fojo S; Akiyama TE; Amar MJ; Paigen BJ; Brewer B; Gonzalez FJ
Biochim Biophys Acta; 2006 Dec; 1761(12):1401-9. PubMed ID: 17110163
[TBL] [Abstract][Full Text] [Related]
15. CLI-095 decreases atherosclerosis by modulating foam cell formation in apolipoprotein E-deficient mice.
Wang XQ; Wan HQ; Wei XJ; Zhang Y; Qu P
Mol Med Rep; 2016 Jul; 14(1):49-56. PubMed ID: 27176130
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of PRMT3 activity reduces hepatic steatosis without altering atherosclerosis susceptibility in apoE knockout mice.
Hoekstra M; Nahon JE; de Jong LM; Kröner MJ; de Leeuw LR; Van Eck M
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1402-1409. PubMed ID: 30776415
[TBL] [Abstract][Full Text] [Related]
17. Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.
Nagashima M; Watanabe T; Shiraishi Y; Morita R; Terasaki M; Arita S; Hongo S; Sato K; Shichiri M; Miyazaki A; Hirano T
Atherosclerosis; 2010 Sep; 212(1):70-7. PubMed ID: 20684826
[TBL] [Abstract][Full Text] [Related]
18. Chlamydia pneumoniae Hijacks a Host Autoregulatory IL-1β Loop to Drive Foam Cell Formation and Accelerate Atherosclerosis.
Tumurkhuu G; Dagvadorj J; Porritt RA; Crother TR; Shimada K; Tarling EJ; Erbay E; Arditi M; Chen S
Cell Metab; 2018 Sep; 28(3):432-448.e4. PubMed ID: 29937375
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Biological Evaluation of Ginsenoside Compound K Derivatives as a Novel Class of LXRα Activator.
Huang Y; Liu H; Zhang Y; Li J; Wang C; Zhou L; Jia Y; Li X
Molecules; 2017 Jul; 22(7):. PubMed ID: 28737726
[TBL] [Abstract][Full Text] [Related]
20. Proatherogenic macrophage activities are targeted by the flavonoid quercetin.
Lara-Guzman OJ; Tabares-Guevara JH; Leon-Varela YM; Álvarez RM; Roldan M; Sierra JA; Londoño-Londoño JA; Ramirez-Pineda JR
J Pharmacol Exp Ther; 2012 Nov; 343(2):296-306. PubMed ID: 22869926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
